North America:
The North American intravenous immunoglobulin market is highly developed, driven by advanced healthcare infrastructure, high prevalence of immunodeficiency disorders, and increasing awareness about IVIG therapies. The United States is the largest contributor to the market, with substantial healthcare expenditure and a strong focus on research and development. Canada also plays a...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian